These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2661597)

  • 21. Antiarrhythmic drugs: present and future.
    Sharma S
    J Assoc Physicians India; 2007 Apr; 55 Suppl():43-6. PubMed ID: 18368867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between implantable cardioverter-defibrillators and class III agents.
    Movsowitz C; Marchlinski FE
    Am J Cardiol; 1998 Aug; 82(4A):41I-48I. PubMed ID: 9737653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs.
    Singh BN; Wadhani N
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S85-97. PubMed ID: 15378133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical usefulness of the Vaughan Williams classification system.
    Cobbe SM
    Eur Heart J; 1987 Mar; 8 Suppl A():65-9. PubMed ID: 3556179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The classification of antiarrhythmic drugs.
    Redetzki HM
    J La State Med Soc; 1989 May; 141(5):17-9. PubMed ID: 2659708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Class III antiarrhythmic drugs].
    Aiba T; Kamakura S
    Nihon Rinsho; 1996 Aug; 54(8):2125-31. PubMed ID: 8810787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of antiarrhythmic agents: electropharmacologic basis and clinical relevance.
    Coromilas J
    Cardiovasc Clin; 1992; 22(1):97-116. PubMed ID: 1309443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class III antiarrhythmics in overdose. Presenting features and management principles.
    Leatham EW; Holt DW; McKenna WJ
    Drug Saf; 1993 Dec; 9(6):450-62. PubMed ID: 8129865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery.
    Bradley D; Creswell LL; Hogue CW; Epstein AE; Prystowsky EN; Daoud EG;
    Chest; 2005 Aug; 128(2 Suppl):39S-47S. PubMed ID: 16167664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.
    Nattel S
    Drugs; 1991 May; 41(5):672-701. PubMed ID: 1712704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha D
    Am J Cardiol; 1997 Oct; 80(8A):16G-23G. PubMed ID: 9354408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact.
    Singh BN
    Eur Heart J; 1993 Nov; 14 Suppl H():14-23. PubMed ID: 7904934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rational scientific basis for subclassification of antiarrhythmic drugs.
    Harrison DC
    Trans Am Clin Climatol Assoc; 1986; 97():43-52. PubMed ID: 3837966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can antiarrhythmic agents be selected based on mechanism of action?
    Lau W; Newman D; Dorian P
    Drugs; 2000 Dec; 60(6):1315-28. PubMed ID: 11152014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification and action of antiarrhythmic drugs.
    Borchard U; Berger F; Hafner D
    Eur Heart J; 1989 Sep; 10 Suppl E():31-40. PubMed ID: 2478366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The working classification of antiarrhythmic drugs based on the pathogenetic approach to treatment of cardiac arrhythmias].
    Lipnitskiĭ TN; Kozlovskiĭ VA
    Lik Sprava; 2002; (8):26-30. PubMed ID: 12669534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of class III antiarrhythmic drugs on the Na(+)-activated K+ channels in guinea-pig ventricular cells.
    Mori K; Saito T; Masuda Y; Nakaya H
    Br J Pharmacol; 1996 Sep; 119(1):133-41. PubMed ID: 8872366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
    Singh BN
    Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.